These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27044878)

  • 21. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).
    Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD
    Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial Hypercholesterolemia Identification by Machine Learning Using Lipid Profile Data Performs as Well as Clinical Diagnostic Criteria.
    Hesse R; Raal FJ; Blom DJ; George JA
    Circ Genom Precis Med; 2022 Oct; 15(5):e003324. PubMed ID: 36154661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
    Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
    Farnier M; Civeira F; Descamps O;
    Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
    Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
    Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
    Climent E; Marco-Benedí V; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Lafuente H; Ortega-Martínez de Victoria E; Brea-Hernando Á; Vila À; Civeira F; Pedro-Botet J
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1594-1603. PubMed ID: 33744038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
    Saavedra YG; Dufour R; Davignon J; Baass A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death.
    Krogh HW; Mundal L; Holven KB; Retterstøl K
    Eur Heart J; 2016 May; 37(17):1398-405. PubMed ID: 26586781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.
    Punzalan FE; Sy RG; Santos RS; Cutiongco EM; Gosiengfiao S; Fadriguilan E; George P; Laurie A
    J Atheroscler Thromb; 2005; 12(5):276-83. PubMed ID: 16205024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia.
    Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B
    J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.